The EPS projection of Humana Inc. (NYSE:HUM) for quarter ended 2016-09-30 is $2.79. Last week, the EPS forecast was $2.79 against target of $2.79, a month earlier. Two months ago, this estimate was $2.79 versus forecast of $2.79 three months earlier, implying a deviation of 0%.
Humana Inc. (NYSE:HUM) stated that 18 days ago, its stock price was positively revised 8 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 5, 5, and 5, correspondingly.
EPS estimate downgrade for Humana Inc. (NYSE:HUM) in the preceding 30, 120, 60 and 90 days were 0, 4, 4, and 4, correspondingly.
Humana Inc. (NYSE:HUM) EPS target for the quarter closed 1 was $2.79, based on 12 recommendations. As reported on 2016-05-04 the EPS was $1.86. The change was $0.05, implying a percentage deviation of 2.76%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Humana Inc. (NYSE:HUM) yearly sales prediction for the fiscal 2017 stands at $14222.102 and the median estimate is at $14053.22. Almost 5 analysts issued sales target.
Highest sales target is $14919 while the lowest target is $13544.6 showing standard deviation of 549.076%.
As many as 5 analysts have sales targets revised upside while 5 reduced sales estimates, implying a deviation of 0%.
Last month, 5 revised sales number projection on upside while 5 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast. Humana Inc. (NYSE:HUM) announced that the deviation in forecast was -0.387%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...